logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Epigenetic Therapy Of Cancer Preclinical Models And Treatment Approaches 1st Edition Manuel Rodrguezparedes

  • SKU: BELL-4606846
Epigenetic Therapy Of Cancer Preclinical Models And Treatment Approaches 1st Edition Manuel Rodrguezparedes
$ 31.00 $ 45.00 (-31%)

4.3

28 reviews

Epigenetic Therapy Of Cancer Preclinical Models And Treatment Approaches 1st Edition Manuel Rodrguezparedes instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 7.05 MB
Pages: 325
Author: Manuel Rodríguez-Paredes, Manel Esteller (auth.), Michael Lübbert, Peter A. Jones (eds.)
ISBN: 9783642384035, 9783642384042, 364238403X, 3642384048
Language: English
Year: 2014
Edition: 1

Product desciption

Epigenetic Therapy Of Cancer Preclinical Models And Treatment Approaches 1st Edition Manuel Rodrguezparedes by Manuel Rodríguez-paredes, Manel Esteller (auth.), Michael Lübbert, Peter A. Jones (eds.) 9783642384035, 9783642384042, 364238403X, 3642384048 instant download after payment.

The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.

Related Products